Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mickie H Cheng

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|June 18, 2013
Insights into type 1 diabetes from the autoimmune polyendocrine syndromesMickie H Cheng, Mark S Anderson
Seminars in Reproductive Medicine|October 5, 2011
Mechanisms and models of immune tolerance breakdown in the ovaryMickie H Cheng, Lawrence M Nelson
Annual Review of Immunology|January 10, 2012
Monogenic autoimmunityMickie H Cheng, Mark S Anderson
Trends in Immunology|June 9, 2007
What's new in the Aire?Mickie H Cheng, Anthony K Shum, Mark S Anderson
Endocrinology|March 31, 2011
Autoimmune oophoritis with multiple molecular targets mitigated by transgenic expression of materNoriyuki Otsuka, Zhi-Bin Tong, Konstantina Vanevski, et al.
The New England Journal of Medicine|February 26, 2010
Acquired autoimmune polyglandular syndrome, thymoma, and an AIRE defectMickie H Cheng, Una Fan, Navdeep Grewal, et al.
Clinical and Translational Science|March 29, 2026
Pharmacokinetics and Safety of Single and Multiple Doses of Molnupiravir in Healthy Male Chinese Adults: An Open-Label, Fixed Sequence, Phase 1 StudyJixiang Zhu, Danning Zhang, Zhiping Liu, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2025
Pharmacokinetics and bioequivalence of a molnupiravir tablet formulation compared with the molnupiravir capsule formulation in healthy adult participants-a randomized, open-label, three-period, crossover studyJulie L Fiore, Yoon Jin, Tycho Heimbach, et al.
Pulmonary Therapy|April 2, 2025
A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial VirusMickie H Cheng, Alex J Mann, Brian M Maas, et al.
Pulmonary Therapy|May 9, 2025
Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial VirusMickie H Cheng, Alex J Mann, Brian M Maas, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Endocrinology, Diabetes, and Obesity|June 18, 2013
Insights into type 1 diabetes from the autoimmune polyendocrine syndromesMickie H Cheng, Mark S Anderson
Seminars in Reproductive Medicine|October 5, 2011
Mechanisms and models of immune tolerance breakdown in the ovaryMickie H Cheng, Lawrence M Nelson
Annual Review of Immunology|January 10, 2012
Monogenic autoimmunityMickie H Cheng, Mark S Anderson
Trends in Immunology|June 9, 2007
What's new in the Aire?Mickie H Cheng, Anthony K Shum, Mark S Anderson
Endocrinology|March 31, 2011
Autoimmune oophoritis with multiple molecular targets mitigated by transgenic expression of materNoriyuki Otsuka, Zhi-Bin Tong, Konstantina Vanevski, et al.
The New England Journal of Medicine|February 26, 2010
Acquired autoimmune polyglandular syndrome, thymoma, and an AIRE defectMickie H Cheng, Una Fan, Navdeep Grewal, et al.
Clinical and Translational Science|March 29, 2026
Pharmacokinetics and Safety of Single and Multiple Doses of Molnupiravir in Healthy Male Chinese Adults: An Open-Label, Fixed Sequence, Phase 1 StudyJixiang Zhu, Danning Zhang, Zhiping Liu, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2025
Pharmacokinetics and bioequivalence of a molnupiravir tablet formulation compared with the molnupiravir capsule formulation in healthy adult participants-a randomized, open-label, three-period, crossover studyJulie L Fiore, Yoon Jin, Tycho Heimbach, et al.
Pulmonary Therapy|April 2, 2025
A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial VirusMickie H Cheng, Alex J Mann, Brian M Maas, et al.
Pulmonary Therapy|May 9, 2025
Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial VirusMickie H Cheng, Alex J Mann, Brian M Maas, et al.
Pageof 2